Preclinical Bioanalytical Aspects of AAV Gene Therapies
Time: 11:45 am
day: Day One
Details:
- Understanding the role of DMPK to model the distribution of AAV gene therapies
- Evaluate in vitro assays for bioanalysis and to the best select vector and way
forward - Discuss immunogenicity considerations
